GPhA Reorganization Starts With Sales Pitch At CEO Summit
This article was originally published in The Pink Sheet Daily
Executive Summary
Board of directors approves transition plan, but search for a new head of the association will await a better estimate of revenue.
You may also be interested in...
GPhA Enters 2011 Bigger And Stronger, But With A Broader Fight On Its Hands
The Generic Pharmaceutical Association is pretty fond of Florida. The group has held its annual meeting in the state almost every year since the association was formed. But regardless of the weather or the hotel amenities, when GPhA convenes in Orlando next month, its members will be slightly disappointed in the venue: Florida is below the national average in the generic utilization rate for its Medicaid program.
GPhA Enters 2011 Bigger And Stronger, But With A Broader Fight On Its Hands
The Generic Pharmaceutical Association is pretty fond of Florida. The group has held its annual meeting in the state almost every year since the association was formed. But regardless of the weather or the hotel amenities, when GPhA convenes in Orlando next month, its members will be slightly disappointed in the venue: Florida is below the national average in the generic utilization rate for its Medicaid program.
ANDA User Fee Negotiations: A Big-Firm Coalition Tackles The Big Backlog
FDA has long negotiated its brand user fee program with two distinct but closely aligned industry groups: the Pharmaceutical Research and Manufacturers of America and the Biotechnology Industry Organization. Now the agency will be using those same discussion techniques as it develops the generic drug user fee program.